Plasma alpha-synuclein detected by single molecule array is increased in PD

Therapeutic approaches to target alpha-synuclein pathology

(2017) Patrik Brundin et al.   EXPERIMENTAL NEUROLOGY

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease

(2017) Chin-Hsien Lin et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Parkinson's disease

(2015) Lorraine V Kalia et al.   LANCET

Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson’s disease

(2015) Xuemei Wang et al.   NEUROSCIENCE LETTERS

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

(2014) Min Shi et al.   ACTA NEUROPATHOLOGICA

APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson Disease

(2014) Ignacio F. Mata et al.   JAMA Neurology

How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale

(2013) Glenn T. Stebbins et al.   MOVEMENT DISORDERS

Blood-based biomarkers for Parkinson's disease

(2013) Lama M. Chahine et al.   PARKINSONISM & RELATED DISORDERS

α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers

(2012) Ana Gorostidi et al.   PLoS One

Plasma α-synuclein in patients with Parkinson's disease with and without treatment

(2010) Raquel Duran et al.   MOVEMENT DISORDERS